BG Medicine Raises $12.8M in Public Offering of Stock | GenomeWeb

NEW YORK (GenomeWeb News) – BG Medicine has completed a public offering of 6 million shares of its common stock, raising net proceeds of around $12.8 million.

The Waltham, Mass.-based cardiovascular diagnostics firm said that the underwriters of the offering also exercised their option to purchase 900,000 additional shares. The offering, which was priced at $2 per share, was launched last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.